Literature DB >> 19555312

Role and significance of statins in the treatment of hypertensive patients.

Mariusz Stepien1, Maciej Banach, Dimitri P Mikhailidis, Anna Gluba, Sverre E Kjeldsen, Jacek Rysz.   

Abstract

BACKGROUND: Statins are the first-line drug therapy in the treatment of hypercholesterolemia. The beneficial clinical impact of statins on the cardiovascular system results not only from their lipid-lowering action but also from other effects. Recently, it has been suggested that statins can reduce blood pressure, especially in hypertensive patients. AIM: The role of the hypotensive action of statins and other mechanisms which reduce cardiovascular risk in hypertensive patients are discussed in this review.
METHODS: Electronic databases searched were [MEDLINE (1966 - February 2009), EMBASE and SCOPUS (1965 - February 2009), DARE (1966 -- February 2009)]. Additionally, abstracts from national and international cardiovascular meetings were studied to identify unpublished studies. The main data search terms were: blood pressure, hypertension, hypercholesterolemia and statins.
FINDINGS: At present, it is difficult to unequivocally assess the impact of statins on blood pressure. However, according to most authors, the impact of statins on the decrease in BP is slight, but significant, especially among patients with hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19555312     DOI: 10.1185/03007990903098081

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  9 in total

1.  The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice.

Authors:  Hoang M Lai; Wilbert S Aronow; Anthony D Mercando; Phoenix Kalen; Harit D Desai; Kaushang Gandhi; Mala Sharma; Harshad Amin; Trung M Lai
Journal:  Med Sci Monit       Date:  2011-12

2.  Malignancy-associated dyslipidemia.

Authors:  Agata Bielecka-Dąbrowa; Simon Hannam; Jacek Rysz; Maciej Banach
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

3.  The effects of statins on blood pressure: current knowledge and future perspectives.

Authors:  Manfredi Rizzo; Giuseppe Montalto; Maciej Banach
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

4.  Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease.

Authors:  Beata Franczyk-Skóra; Anna Gluba; Maciej Banach; Jacek Rysz
Journal:  Arch Med Sci       Date:  2013-12-26       Impact factor: 3.318

5.  Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.

Authors:  Maciej Banach; Manfredi Rizzo; Peter P Toth; Michel Farnier; Michael H Davidson; Khalid Al-Rasadi; Wilbert S Aronow; Vasilis Athyros; Dragan M Djuric; Marat V Ezhov; Robert S Greenfield; G Kees Hovingh; Karam Kostner; Corina Serban; Daniel Lighezan; Zlatko Fras; Patrick M Moriarty; Paul Muntner; Assen Goudev; Richard Ceska; Stephen J Nicholls; Marlena Broncel; Dragana Nikolic; Daniel Pella; Raman Puri; Jacek Rysz; Nathan D Wong; Laszlo Bajnok; Steven R Jones; Kausik K Ray; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2015-03-14       Impact factor: 3.318

6.  Antihypertensive effects of rosuvastatin in patients with hypertension and dyslipidemia: A systemic review and meta-analysis of randomized studies.

Authors:  Sungjae Lee; Seungwon Yang; Min Jung Chang
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

Review 7.  Lipid, blood pressure and kidney update 2013.

Authors:  Maciej Banach; Corina Serban; Wilbert S Aronow; Jacek Rysz; Simona Dragan; Edgar V Lerma; Mugurel Apetrii; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2014-02-27       Impact factor: 2.370

8.  Discussion around statin discontinuation in older adults and patients with wasting diseases.

Authors:  Maciej Banach; Maria-Corina Serban
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-02-29       Impact factor: 12.910

9.  Unripe Rubus coreanus Miquel Extract Containing Ellagic Acid Regulates AMPK, SREBP-2, HMGCR, and INSIG-1 Signaling and Cholesterol Metabolism In Vitro and In Vivo.

Authors:  Ki Hoon Lee; Eui-Seon Jeong; Goeun Jang; Ju-Ryun Na; Soyi Park; Wan Seok Kang; Eun Kim; Hakjoon Choi; Jin Seok Kim; Sunoh Kim
Journal:  Nutrients       Date:  2020-02-26       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.